These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 631129)

  • 1. Decreased heparin sensitivity of cycholhexanedione-modified thrombin.
    Machovich R; Staub M; Patthy L
    Eur J Biochem; 1978 Feb; 83(2):473-7. PubMed ID: 631129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased heparin sensitivity of cyclohexanedione-modified factor Xa.
    Blaskó G; Machovich R
    Thromb Haemost; 1979 Aug; 42(2):556-63. PubMed ID: 505364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.
    Danishefsky I; Ahrens M; Klein S
    Biochim Biophys Acta; 1977 Jun; 498(1):215-22. PubMed ID: 560216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disulfide bond in antithrombin is required for heparin-accelerated thrombin inactivation.
    Longas MO; Ferguson WS; Finlay TH
    J Biol Chem; 1980 Apr; 255(8):3436-41. PubMed ID: 7364749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of heparin through thrombin on blood coagulation.
    Machovich R
    Biochim Biophys Acta; 1975 Nov; 412(1):13-7. PubMed ID: 1191673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of collagen on thrombin inactivation by antithrombin-III and heparin.
    Blaskó G; Bédi J; Machovich R; Pálos LA
    Haematologia (Budap); 1977; 11(1-2):163-8. PubMed ID: 615087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catalysis by heparin of the reaction between thrombin and antithrombin.
    Evington JR; Feldman PA; Luscombe M; Holbrook JJ
    Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):329-38. PubMed ID: 611046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin cofactor and plasma antithrombin in relation to the mechanism of inactivation of thrombin by heparin.
    Porter P; Porter MC; Shanberge JN
    Clin Chim Acta; 1967 Aug; 17(2):189-200. PubMed ID: 6035543
    [No Abstract]   [Full Text] [Related]  

  • 13. The inactivation of thrombin and plasmin by antithrombin III in the presence of sepharose-heparin.
    Hatton MW; Regoeczi E
    Thromb Res; 1977 May; 10(5):645-60. PubMed ID: 142314
    [No Abstract]   [Full Text] [Related]  

  • 14. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.
    Marcum JA; McKenney JB; Rosenberg RD
    J Clin Invest; 1984 Aug; 74(2):341-50. PubMed ID: 6746897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-sensitive and nonsensitive forms of thrombin.
    Machovich R
    Biochim Biophys Acta; 1975 Jul; 400(1):62-8. PubMed ID: 1170899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin.
    Rezaie AR
    Protein Sci; 1998 Feb; 7(2):349-57. PubMed ID: 9521111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation-fibrinolytic mechanism and the action of heparin.
    Rosenberg RD
    Adv Exp Med Biol; 1975; 52():217-37. PubMed ID: 235831
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin III and heparin inactivation in thrombin involving reactions.
    Marciniak E
    Thromb Haemost; 1977 Aug; 38(2):486-93. PubMed ID: 579490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.